Skip to content

High-throughput sequencing to study the impact of dynamic changes of intestinal flora in patients with intrahepatic cholestasis of pregnancy before and after delivery on disease progression

High-throughput sequencing to study the impact of dynamic changes of intestinal flora in patients with intrahepatic cholestasis of pregnancy before and after delivery on disease progression

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050882
Enrollment
Unknown
Registered
2021-09-06
Start date
2020-03-24
Completion date
Unknown
Last updated
2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrahepatic cholestasis of pregnancy

Interventions

Intrahepatic cholestasis of pregnancy group:No
Control group:No

Sponsors

Chengdu Women's and Children's Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Experimental group: patients who were diagnosed as ICP for the first time after 14 weeks of gestation, had fasting blood total bile acid >= 10 umol/l, and had not been treated before; 2. Control group: patients who corresponded to the study group's gestational age without comorbidities and complications Pregnant women, without pregnancy complications and complications.

Exclusion criteria

Exclusion criteria: 1. People who have undergone major gastrointestinal surgery (cholecystectomy, appendectomy) and major intestinal resection within 5 years; 2. People who have hepatobiliary disease, inflammatory bowel disease, irritable bowel syndrome, autoimmune diseases; 3. People with hypertension during pregnancy, gestational diabetes or other pregnancy complications and medical complications; 4. People who have a history of mental illness and cannot cooperate.

Design outcomes

Primary

MeasureTime frame
Intestinal flora;

Countries

China

Contacts

Public ContactYang Xiao

Chengdu Women's and Children's Central Hospital

wcchgcptg@163.com+86 28 61866009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026